Nilotinib - Azurity Pharmaceuticals
At a glance
- Drug Originator Azurity Pharmaceuticals
- Drug Class Anilides; Aniline compounds; Antineoplastics; Benzamides; Fluorinated hydrocarbons; Imidazoles; Ketones; Pyridines; Pyrimidines; Small molecules; Toluenes
- Mechanism of Action Bcr-Abl tyrosine kinase inhibitors; Platelet-derived growth factor alpha receptor antagonists; Platelet-derived growth factor beta receptor antagonists; Proto-oncogene protein c-kit inhibitors
- USA Patent Applicants AZURITY
- USA Patents 2
- NDAs 1
- International Patents 6
- Patent Applications 4,662

Disclaimer